The 2017 Scrip Awards recognize WuXi NextCODE for enabling the pharmaceutical industry to take advantage of genomics.
The award, announced at the 13th annual Scrip Awards dinner in London, singled out WuXi NextCODE’s unique Contract Genomics Organization (CGO) capabilities for putting the full power of our world-leading genomics platform into the hands of biotechnology and pharmaceutical companies around the world.
WuXi NextCODE was selected from among many leading service providers and half a dozen finalists by an expert panel of judges comprised of independent, senior industry experts from around the world.
“Our aim is to enable anyone to use the genome to the benefit of people everywhere, so it is particularly gratifying to see our work recognized by the industry that creates new medicine,” said Hannes Smarason, CEO of WuXi NextCODE.
“We have built our CGO business to make it possible for organizations around the world to access our comprehensive range of best-in-class capabilities in genomics. We make it possible for biotechnology and pharmaceutical companies to take advantage of the best technology and largest global datasets, and to do so precisely according to their needs rather than a major fixed cost.”
WuXi NextCODE’s global platform is unique in offering truly comprehensive and integrated solutions for sequencing and querying genomic Big Data. Solutions include: